An interventional study of Fiber Intervention and Standard Weight Loss Education in Obesity, sponsored by Oklahoma State University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Oklahoma State University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The overall objective of this three-arm randomized controlled trial is to compare a dietary fiber-focused behavioral intervention to standard weight loss education for improving eating-related behavior and cognition, weight, and metabolic markers of chronic disease risk in a population of adults with obesity.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's enrollment of 63 is close to the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Oklahoma State University is the lead sponsor of 39 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Individuals in this arm will be given instruction on how to increase fiber intake,
Behavioral: Fiber Intervention
Individuals in this arm will be given standard weight loss education
Behavioral: Standard Weight Loss Education
Individuals in this arm will be given education on both fiber and standard weight loss
Behavioral: Fiber Intervention · Behavioral: Standard Weight Loss Education
Group education and phone-based motivational interviewing to gradually increase dietary fiber consumption to 30-35 grams per day.
Group education and phone-based motivational interviewing to promote current evidence-based behaviors to promote weight loss via achieving a negative energy balance.
Body weight
Measure of body weight/mass
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Body composition (fat mass, lean mass)
Dual x-ray absorptiometry (DEXA) scans
Time frame: Measured at baseline (time 1, month 0) and post-observation (time 3, month 27)
Fecal short chain fatty acids
Taken from fecal samples collected at home
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Fecal bacteria measured using 16S ribosomal ribonucleic acid (rRNA) sequencing
Will include measures of diversity, abundance, etc.
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Total Cholesterol
Measured via blood samples (unit= milligram/deciliter (mg/dL))
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Fasting blood glucose
Measured via blood samples (unit=mg/dL)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 33, month 27)
Healthy Eating Index Scores measured using Health Eating Index 2020 (HEI-2020)
Taken from 3 day diet records (score range=0-100, higher=better diet quality)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Three-Factor Eating Questionnaire
Resulting scores in uncontrolled eating (range=9-36), cognitive restraint (range=3-12), and emotional eating (range=6-24); higher scores indicate more of that particular eating behavior
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Implicit Association Test
Represented with a total D variable (No range, but more negative = greater preference for unprocessed food)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Behavioral Inhibition System/Behavioral Approach System (BIS/BAS) Scale
Score ranges from 20 to 80, with higher scores indicating greater behavioral inhibition and behavioral activation
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Executive Function: Tower Test (Delis-Kaplan Executive Function System)
Total Achievement Score (range=0-30, higher = higher executive function)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Executive Function: Color-Word Interference Test (Delis-Kaplan Executive Function System)
Scaled inhibition/switching scores (score range=1-19, higher = higher executive function)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Skin Carotenoid scores measured via the Veggie Meter
Veggie Meter; score range 0-800 (higher=greater skin carotenoids (i.e., consumption of more fruits/vegetables)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
High-density lipoprotein (HDL) cholesterol
Measured via blood samples (unit=mg/dL)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Low-density lipoprotein (LDL) cholesterol
Measured via blood samples (unit=mg/dL)
Time frame: Measured at baseline (time 1, month 0), post-intervention (time 2, month 15), and post-observation (time 3, month 27)
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2023 (actual). Primary completion is estimated for Mar 2028, 56 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 56 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Jan 2026 → Mar 2028 and completion Feb 2026 → Mar 2029.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oklahoma State University